ArticleOncology letters2018

Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial.

Li Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.